Syschem (India) Limited (BOM:531173)

Market Cap	2.05B +13.7%
Revenue (ttm)	5.45B +62.5%
Net Income	82.03M
EPS	1.47
Shares Out	43.51M
PE Ratio	32.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,971
Average Volume	39,311
Open	47.85
Previous Close	46.70
Day's Range	46.60 - 47.85
52-Week Range	35.33 - 62.00
Beta	-0.98
RSI	39.41
Earnings Date	May 7, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and ...

• Industry: Industrial Organic Chemicals
• Founded: 1993
• Employees: 115
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531173

Financial Performance

In fiscal year 2025, Syschem (India)'s revenue was 3.86 billion, an increase of 65.43% compared to the previous year's 2.33 billion. Earnings were 4.60 million, a decrease of -83.34%.